AUPH - Aurinia Pharmaceuticals Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.21
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.50
DETAILS
HIGH:
$16.00
LOW:
$15.00
MEDIAN:
$15.50
CONSENSUS:
$15.50
UPSIDE:
6.24%
Market Cap:
1.92B
Volume:
894,800
Avg Volume:
1,073,651
52 Week Range:
6.55-16.54
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.54
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
130
IPO Date:
2014-09-03
EPS (TTM):
0.04
P/E Ratio:
223.34
Revenue (TTM):
235.13M
Total Assets:
550.64M
Total Debt:
79.37M
Cash & Equiv:
83.43M
Rev Growth (5Y):
274.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
2.7%
Debt/Equity:
0.21
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.23 | $0.16 | +43.8% | $73.5M | $74.7M | -1.6% |
| 2025-07-31 | $0.16 | $0.17 | -5.9% | $70.0M | $67.7M | +3.4% |
| 2025-05-12 | $0.16 | $0.08 | +100.0% | $62.5M | $64.6M | -3.4% |
| 2025-02-27 | $0.09 | $0.03 | +200.0% | $59.9M | $61.8M | -3.2% |
| 2024-11-07 | $0.10 | $0.01 | +566.7% | $67.8M | $65.1M | +4.2% |
| 2024-08-01 | $0.02 | $0.02 | +20.0% | $57.2M | $55.0M | +3.9% |
| 2024-05-02 | $-0.03 | $-0.17 | +82.4% | $50.3M | $47.5M | +6.0% |
| 2024-04-16 | $-0.07 | $-0.14 | +50.0% | $45.1M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 235.13M | 175.51M | 134.03M | 45.60M | 50.12M | 318,000 | 463,000 | 420,000 | 173,000 | 235,000 | 278,000 | 948,561 |
| Net Income | 5.75M | (78.02M) | (108.18M) | (180.97M) | (102.68M) | (88.39M) | (64.12M) | (70.79M) | (23.30M) | (18.61M) | (16.65M) | (2.55M) |
| EPS | 0.04 | -0.54 | -0.76 | -1.40 | -0.87 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 | -0.40 |
| Total Assets | 550.64M | 548.06M | 470.86M | 543.37M | 463.66M | 324.30M | 145.86M | 189.85M | 57.00M | 33.57M | 52.38M | 23.14M |
| Total Debt | 79.37M | 97.61M | 8.09M | 8.74M | 8.41M | 0 | 0 | 0 | 0 | 0 | 0 | 1.32M |
| Cash & Equivalents | 83.43M | 48.88M | 94.17M | 231.90M | 272.35M | 306.02M | 117.97M | 165.63M | 39.65M | 5.76M | 22.71M | 1.82M |
| Operating Cash Flow | 44.39M | (33.46M) | (79.53M) | (157.69M) | (69.86M) | (63.59M) | (51.61M) | (41.17M) | (18.71M) | (17.77M) | (16.90M) | (4.52M) |
| Free Cash Flow | 44.11M | (34.18M) | (79.82M) | (159.19M) | (77.20M) | (63.69M) | (51.69M) | (41.19M) | (18.74M) | (17.82M) | (16.99M) | (4.63M) |
| FCF per Share | 0.31 | -0.24 | -0.56 | -1.23 | -0.65 | -0.68 | -0.61 | -0.54 | -0.53 | -0.55 | -0.59 | -0.73 |
| Book Value | 377.48M | 377.95M | 405.44M | 479.09M | 407.75M | 298.60M | 112.58M | 165.74M | 35.95M | 19.96M | 45.11M | 13.30M |
| Cash & ST Investments | 358.48M | 350.49M | 389.39M | 466.08M | 398.33M | 306.02M | 125.86M | 173.46M | 39.65M | 15.75M | 32.70M | 1.82M |
| ROC Equity | 0.02 | -0.21 | -0.27 | -0.38 | -0.25 | -0.30 | -0.57 | -0.43 | -0.65 | -0.93 | -0.37 | -0.19 |